Дискуссионные вопросы влияния глюкокортикоидной терапии беременных на здоровье детей
Аннотация
Ключевые слова: глюкокортикоиды, беременность, отдаленные последствия, поведение, дети.
Об авторах
А.В. ШайтароваЕ.Б. Храмова
Л.А. Суплотова
Список литературы
1. Храмова Е.Б. Эпидемиология, скрининг, диагностика врожденной дисфункции коры надпочечников в Западно–Сибирском регионе. Автореф. дис. … докт. мед. наук. Тюмень. 2007. С. 39.
2. Charmandari E., Kino T., Souvatzoglou E., Chrousos G.P. Pediatric stress: hormonal mediators and human development. Horm. Res. 2003; 59 (4): 161–179.
3. Lupien S.J., Wilkinson C.W., Briere S. et al. The modulatory effects of corticosteroids on cognition: studies in young human populations. Psycho-neuroendocrinology. 2002; 27 (3): 401–416.
4. Kapoor A., Petropoulos S., Matthews S.G. Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain. Res. Rev. 2008; 57: 586–595.
5. Weinstock M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog. Neurobiol. 2001; 65 (5): 427–451.
6. Huizink A.C., Mulder E.J., Buitelaar J.K. Prenatal stress and risk for psychopathology: specific effects or induction of general susceptibility? Psychol. Bull. 2004; 130 (1): 115–142.
7. Rice F., Jones I., Thapar A. The impact of gestational stress and prenatal growth on emotional problems in offspring: a review. Acta. Psychiatr. Scand. 2007; 115 (3): 171–183.
8. Dietrich K.N. Environmental neurotoxicants and psychological development. In: Pediatric Neuropsychology: Research, Theory and Practice. Ed. Yeates K.O., Ris M.D., Taylor H.G. New York: The Guilford Press. 2000. Р. 206–234.
9. Belanoff J.K., Gross K., Yager A., Schatzberg A.F. Corticosteroids and cognition. J. Psychiatr. Res. 2001; 35 (3): 127–145.
10. Dennis M. Childhood medical disorders and cognitive impairment: biological risk, time, development, and reserve. In: Pediatric Neuropsychology: Research, Theory, and Practice. Ed. Yeates K.O., Ris M.D., Taylor H.G. New York: The Guilford Press. 2000. Р. 206–234.
11. Matthews S.G. Antenatal glucocorticoids and the developing brain mechanisms of action. Semin. Neonatol. 2001; 6 (4): 309–317.
12. McEwen B., Chao H., Spencer R. et al. Corticosteroid receptors in brain: relationship of receptors to effects in stress and aging. Ann. NY Acad. Sci. 1987; 512: 394–401.
13. Lajic S., Wedell A., Bui T.H. et al. Long term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 1998; 83 (11): 3872–3880.
14. Seckl J.R., Meaney M.J. Glucocorticoid programming. Ann. NY Acad. Sci. 2004; 1032: 63–84.
15. Barker D.J. In utero programming of chronic disease. Clin. Sci. (Lond). 1998; 95 (2): 115–128.
16. Barker D.J. Intrauterine programming of adult disease. Mol. Med. Today. 1995; 1 (9): 418–423.
17. Barker D.J., Eriksson J.G., Forsen T., Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int. J. Epidemiol. 2002; 31 (6): 1235–1239.
18. Dalziel S.R., Walker N.K., Parag V. et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30 year follow up of a randomised controlled trial. Lancet. 2005; 365 (9474): 1856–1862.
19. Dalziel S.R., Lim V.K., Lambert A. et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ. 2005; 331 (7518): 665.
20. French N.P., Hagan R., Evans S.F. et al. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am. J. Obstet. Gynecol. 2004; 190 (3): 588–595.
21. Wapner R.J., Sorokin Y., Mele L. et al. Long term outcomes after repeat doses of antenatal corticosteroids. N. Engl. J. Med. 2007; 357 (12): 1190–1198.
22. Yeh T.F., Lin Y.J., Lin H.C. et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N. Engl. J. Med. 2004; 350 (13): 1304–1313.
23. Trautman P.D., Meyer–Bahlburg H.F., Postelnek J., New M.I. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology. 1995; 20 (4): 439–449.
24. Meyer–Bahlburg H.F., Dolezal C., Baker S.W. et al. Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone. J. Clin. Endocrinol. Metab. 2004; 89 (2): 610–614.
25. Hirvikoski T., Nordenstrom A., Lindholm T. et al. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J. Clin. Endocrinol. Metab. 2007; 92 (2): 542–548.
26. De Vries A., Holmes M.C., Heijnis A. et al. Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic pituitary adrenal axis function. J. Clin. Invest. 2007; 117 (4): 1058–1067.
27. Дыгало Н.Н. Психонейроэндокринные свойства взрослого организма предопределяются особенностями экспрессии генов в раннем онтогенезе. Российский физиологический журнал им. И.М. Сеченова. 2007; 93 (11): 1229–1235.
28. Drake A.J., Walker B.R. The intergenerational effects of fetal programming: nongenomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J. Endocrinol. 2004; 180 (1): 1–16.
29. Drake A.J., Walker B.R., Seckl J.R. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005; 288 (1): 34–38.
30. Seckl J.R. Prenatal glucocorticoids and long-term programming. Eur. J. Endocrinol. 2004; 151 (3): 49–62.
31. Emgard M., Paradisi M., Pirondi S. et al. Prenatal glucocorticoid exposure affects learning and vulnerability of cholinergic neurons. Neurobiol. Aging. 2007; 28 (1): 112–121.
32. Kreider M.L., Aldridge J.E., Cousins M.M. et al. Disruption of rat forebrain development by glucocorticoids: critical perinatal periods for effects on neural cell acquisition and on cell signaling cascades 41 mediating noradrenergic and cholinergic neurotransmitter/neurotrophic responses. Neuropsychopharmacology. 2005; 30 (10): 1841–1855.
33. Slotkin T.A., Kreider M.L., Tate C.A., Seidler F.J. Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems. Neuropsychopharmacology. 2006; 31 (5): 904–911.
34. Dodic M., Tersteeg M., Jefferies A. et al. Prolonged low-dose dexamethasone treatment, in early gestation, does not alter blood pressure or renal function in adult sheep. J. Endocrinol. 2003; 179 (2): 275–280.
35. Patel P.D., Lopez J.F., Lyons D.M. et al. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J. Psychiatr. Res. 2000; 34 (6): 383–392.
36. Sanchez M.M., Young L.J., Plotsky P.M., Insel T.R. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J. Neurosci. 2000; 20 (12): 4657–4668.
Для цитирования:
Шайтарова А., Храмова Е., Суплотова Л. Дискуссионные вопросы влияния глюкокортикоидной терапии беременных на здоровье детей. Вопросы современной педиатрии. 2011;10(2):82-85.
For citation:
Shaytarova A., Khramova Y., Suplotova L. Discussion questions of influence of corticosteroid treatment in pregnant women on children’s health. Current Pediatrics. 2011;10(2):82-85. (In Russ.)
Послать статью по эл. почте 